PHARMAVITE LLC for PHARMAVITE LLC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
Support for COVID-19 relief packages; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Budget/Appropriations BUD
Increase funding for the Office of Dietary Supplement Programs within FDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Taxation/Internal Revenue Code TAX
S. 12 - Health Savings Act, a bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts; all provisions relating to dietary supplements S. 4463 - a bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Consumer Issues/Safety/Products CSP
H.R.6058-SHOP SAFE act, a bill to provide for contributory liability for certain electronic commerce platforms for use of a counterfeit mark by a third party on such platforms; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT | — |
Food Industry (safety, labeling, etc.) FOO
H.R. 8179, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, a bill to to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement; all provisions relating to dietary supplements
| Lobbyist | Covered position, as disclosed |
|---|---|
| INGRID LEBERT New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.